- +2
George Perkovich, Jessica Tuchman Mathews, Joseph Cirincione, …
{
"authors": [
"Jon Wolfsthal"
],
"type": "other",
"centerAffiliationAll": "dc",
"centers": [
"Carnegie Endowment for International Peace"
],
"collections": [
"Korean Peninsula"
],
"englishNewsletterAll": "ctw",
"nonEnglishNewsletterAll": "",
"primaryCenter": "Carnegie Endowment for International Peace",
"programAffiliation": "NPP",
"programs": [
"Nuclear Policy"
],
"projects": [],
"regions": [
"East Asia",
"North Korea"
],
"topics": [
"Nuclear Policy"
]
}Source: Getty
Our Missile Defenses Go to 11
Despite spending tens of billions of dollars on missile defense over the last 30 years, the United States remains unable to shoot down North Korean ICBMs.
Source: Foreign Policy
I usually write longer, detailed essays for this column but today’s submission is simpler. And it has a simple message. Missile defense will not protect the United States from North Korean missiles. I know a lot of people think the opposite is true. Even President Donald Trump has asserted we have a 97 percent chance of shooting down a North Korean intercontinental ballistic missile (ICBM). But, as they say, “um, no.”
It would make sense for you to scratch your head and ask how can we have spent tens of billions of dollars over 30 years and still not be able to shoot down a couple of North Korea missiles. But, sorry, we can’t.
This is true for a whole host of reasons, but let’s get right to the chase. Our missile defenses don’t work all that well (better than they used to, but far from reliable and very far from perfect) and we don’t have very many of them. It is like the old joke about the married couple. The wife complains “the food at this restaurant is terrible!” To which her husband responds: “Yeah, and the portions are small, too.”
Current U.S. military planning would shoot four ground-based interceptors (GBIs) in Alaska or California at each incoming North Korean ICBM. Do the math. We shoot four at each incoming missile because each interceptor has about a 25 percent chance of working: i.e. hitting its target. And that assumes everything goes right. So far, however, little goes right for our GBIs and none have ever taken down an ICBM in a realistic, real-time, no-notice test. In fact, the reason the United States purchased so few GBIs in the Obama years is because the ones we had already purchased did not work all that well. Time and money were needed to fix major systemic problems. They’re better now, but still far from perfect.
This article was originally published in Foreign Policy
Read the article
About the Author
Former Nonresident Scholar, Nuclear Policy Program
Jon Wolfsthal was a nonresident scholar with the Nuclear Policy Program.
- Universal Compliance: A Strategy for Nuclear Security<br>With 2007 Report Card on ProgressReport
- 10 Plus 10 Doesn’t Add UpArticle
Jon Wolfsthal
Recent Work
Carnegie does not take institutional positions on public policy issues; the views represented herein are those of the author(s) and do not necessarily reflect the views of Carnegie, its staff, or its trustees.
More Work from Carnegie China
- The Spring and Autumn of Chinese PoliticsCommentary
China’s political future will be shaped between now and next October. As the Communist Party enters its intense “campaign season” to prepare for a major political transition in 2027, reading Beijing's actions and responses may become more difficult as domestic politics weigh on its behavior more than usual.
Damien Ma
- Can China Turn Its Small Modular Reactor Ambitions into Commercial Reality?Article
China has showcased its engineering prowess with small modular reactor demonstration projects. But turning these technological achievements into commercial success will be a greater challenge.
Tong Zhao
- Untangling the Nuclear Knot: A Constructive Agenda for Managing China’s Nuclear Relations with the United States and Its AlliesPaper
The nuclear relationship between China and the United States is increasingly shaped by widening perception gaps rather than deliberate strategic design.
Tong Zhao
- Caught in the Middle: Chinese Biotech Firms’ Divergent Responses to U.S. SanctionsCommentary
Chinese biotech companies have been on the receiving end of U.S. economic coercion. Yet their responses have differed significantly because firm and state interests are not uniformly aligned. For Washington, treating all Chinese tech firms the same, irrespective of their actual interests, risks pushing them farther into Beijing’s corner.
Xue Gong
- China’s Energy Security Doesn’t Run Through Hormuz but Through the Electrification of EverythingCommentary
Across Asia, China is better positioned to withstand energy shocks from the fallout of the Iran war. Its abundant coal capacity can ensure stability in the near term. Yet at the same time, the country’s energy transition away from coal will make it even less vulnerable during the next shock.
Damien Ma